At CNSide Diagnostics, LLC, we are committed to advancing the field of oncology diagnostics through strategic partnerships and collaborations. We invite research institutions, pharmaceutical companies, and healthcare providers to join us in leveraging the CNSide® CSF Assay Platform’s capabilities. Together, we can enhance the detection and treatment of Leptomeningeal Metastases (LM), ultimately improving patient outcomes. Explore how your organization can benefit from collaborating with us on innovative research projects, clinical trials, and more.